<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001301" GROUP_ID="MENSTR" ID="138199092817000545" MERGED_FROM="" MODIFIED="2011-06-13 05:03:46 +0200" MODIFIED_BY="Jane Clarke" NOTES="&lt;p&gt;Exported from Review Manager 4.2.2&lt;br&gt;Short title (no longer in use): Subferility: micromanipulation: ICSI&lt;/p&gt;&lt;p&gt;Left male factor infertility, SUZI, PZD and additional IVF out.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2011-05-16 22:58:57 +1000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="MVR461" REVMAN_SUB_VERSION="5.1.1" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2011-06-13 05:03:46 +0200" MODIFIED_BY="Jane Clarke">
<TITLE MODIFIED="2011-02-08 10:49:03 +1100" MODIFIED_BY="Jane Clarke">Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in couples with non-male subfertility</TITLE>
<CONTACT MODIFIED="2011-06-13 05:03:46 +0200" MODIFIED_BY="Jane Clarke"><PERSON ID="CB5A0DED82E26AA200C221D729CDD565" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Minouche</FIRST_NAME><MIDDLE_INITIALS>ME</MIDDLE_INITIALS><LAST_NAME>van Rumste</LAST_NAME><POSITION>Gynaecologist</POSITION><EMAIL_1>minouchevr@hotmail.com</EMAIL_1><EMAIL_2>minouche.v.rumste@cze.nl</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Catharina Hospital</ORGANISATION><ADDRESS_1>Michelangelolaan 2</ADDRESS_1><CITY>Eindhoven</CITY><ZIP>5602ZA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 40 2397100</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-06-13 05:03:46 +0200" MODIFIED_BY="Jane Clarke"><PERSON ID="CB5A0DED82E26AA200C221D729CDD565" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Minouche</FIRST_NAME><MIDDLE_INITIALS>ME</MIDDLE_INITIALS><LAST_NAME>van Rumste</LAST_NAME><POSITION>Gynaecologist</POSITION><EMAIL_1>minouchevr@hotmail.com</EMAIL_1><EMAIL_2>minouche.v.rumste@cze.nl</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Catharina Hospital</ORGANISATION><ADDRESS_1>Michelangelolaan 2</ADDRESS_1><CITY>Eindhoven</CITY><ZIP>5602ZA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 40 2397100</PHONE_1></ADDRESS></PERSON><PERSON ID="14563" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Johannes</FIRST_NAME><MIDDLE_INITIALS>LH</MIDDLE_INITIALS><LAST_NAME>Evers</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jlh.evers@mumc.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics &amp; Gynaecology</DEPARTMENT><ORGANISATION>Division of Reproductive Medicine</ORGANISATION><ADDRESS_1>Maastricht University Medical Center P.O. Box 5800</ADDRESS_1><CITY>Maastricht</CITY><ZIP>6202 AZ</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 43 387 6764</PHONE_1><FAX_1>+31 43 387 4765</FAX_1></ADDRESS></PERSON><PERSON ID="9CE26E7F82E26AA200CD32E53036321F" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Cindy</FIRST_NAME><LAST_NAME>Farquhar</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>c.farquhar@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>University of Auckland</ORGANISATION><ADDRESS_1>FMHS Park Road</ADDRESS_1><ADDRESS_2>Grafton</ADDRESS_2><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 6309943</PHONE_1><FAX_1>+64 9 6309858</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-05-01 23:11:41 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 2/4/03&lt;/p&gt;&lt;p&gt;New studies found but not yet included or excluded: 6/15/02&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 12/16/02&lt;/p&gt;&lt;p&gt;Conclusions changed: 12/19/02&lt;/p&gt;&lt;p&gt;Feedback added: 2/2/03&lt;/p&gt;&lt;p&gt;Reformatted: 10/4/99&lt;/p&gt;" NOTES_MODIFIED="2011-05-01 23:11:41 +1000" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="2" YEAR="2003"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="8" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="24" MONTH="8" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2003"/>
</DATES>
<WHATS_NEW MODIFIED="2011-05-01 23:33:09 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Since ICSI has proven to be the therapy of choice for couples with severe male factor infertility in whom IVF is not possible, the comparison has been narrowed down to ICSI versus IVF in couples with nonmale factor subfertility.&lt;br&gt;&lt;br&gt;ICSI has by far surpassed PZD en SUZI, therefore the title has been changed from &amp;quot;Inta-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation&amp;quot; to &amp;quot;ICSI versus IVF in couples with nonmale subfertility&amp;quot;.&lt;/p&gt;" NOTES_MODIFIED="2011-05-01 23:33:09 +1000" NOTES_MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2011-02-04 09:53:35 +1100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>This review will no longer be updated as there have been no new studies identified in the most recent update and the likelihood of new studies emerging or ever changing the findings is limited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-01-24 09:12:31 +1100" MODIFIED_BY="Julie A Brown">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-01-24 09:12:31 +1100" MODIFIED_BY="Julie A Brown">
<DATE DAY="24" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Review updated and Revman 5 formatting undertaken. No new trials identified. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-19 12:53:00 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="4" MONTH="2" YEAR="2003"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Auckland, School of Medicine, Auckland</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>SWOL</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-05-16 22:42:53 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-05-16 21:51:25 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2011-05-16 21:49:46 +1000" MODIFIED_BY="[Empty name]">Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in couples with non-male subfertility</TITLE>
<SUMMARY_BODY MODIFIED="2011-05-16 21:51:25 +1000" MODIFIED_BY="[Empty name]">
<P>IVF gives better fertilisation results than ICSI in couples with male factor subfertility. Pregnancy rates found after IVF and ICSI are comparable for couple with non-male subfertility. If anything, ICSI does not improve on the IVF outcome in these couples.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-05-16 21:49:15 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-05-16 21:41:44 +1000" MODIFIED_BY="[Empty name]">
<P>In vitro fertilisation (IVF) as treatment for male factor subfertility is associated with lower fertilisation and pregnancy rates than for other indications. Since the late 1980s several assisted fertilisation techniques have emerged and have been rapidly developed to try to enhance results for couples with male factor subfertility, or to help couples with severe male factor for whom conventional IVF was not possible. The techniques of partial zona dissection (PZD) and of subzonal microinjection of spermatozoa into the perivitelline space (SUZI) are by far surpassed by the technique of intra-cytoplasmatic sperm injection (ICSI). ICSI has proven to be the therapy of choice for couples with severe male factor subfertility. This is an update of the review, first published in 1999, comparing ICSI to IVF for couples with non-male fertility.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-01-24 08:15:18 +1100" MODIFIED_BY="Julie A Brown">
<P>To investigate whether ICSI improves live birth rate in comparison to IVF in couples with non-male subfertility.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-05-16 21:46:32 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (searched 30 May 2002), the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2002, Issue 2), PubMed (January 1992 to July 2002) and reference lists of articles. This search was re-run for the update (August 2010).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-05-16 21:47:12 +1000" MODIFIED_BY="[Empty name]">
<P>Trials were included if they compared the effects of the IVF and ICSI techniques on livebirths, pregnancy and fertilisation outcomes. Only randomised clinical studies were included in this review.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-05-16 21:39:20 +1000" MODIFIED_BY="[Empty name]">
<P>One study met the inclusion criteria for this review. The study compared ICSI with IVF within couples with non-male infertility. Data was extracted independently by two review authors.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-05-16 21:49:15 +1000" MODIFIED_BY="[Empty name]">
<P>There were no data comparing live birth rates. The single identified study did not find a difference in pregnancy rates (OR 1.4, 95% CI 0.95 to 2.2). There were no data on miscarriage rates from the one identified randomised clinical trial, nor on other adverse events that may be of concern such as congenital malformations.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-01-24 08:18:26 +1100" MODIFIED_BY="Julie A Brown">
<P>Whether ICSI should be preferred to IVF for cases of non-male factor subfertility remains an open question. Further research should report live birth rates and adverse events.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-05-16 22:39:11 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2011-05-16 22:21:55 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2011-05-16 22:20:50 +1000" MODIFIED_BY="[Empty name]">
<P>In vitro fertilisation (IVF) and embryo transfer as treatment for male factor subfertility is associated with lower fertilisation and pregnancy rates than for other indications (<LINK REF="REF-Acosta-1986" TYPE="REFERENCE">Acosta 1986</LINK>; <LINK REF="REF-Lanzendorf-1988" TYPE="REFERENCE">Lanzendorf 1988</LINK>; <LINK REF="REF-Mahadevan-1983" TYPE="REFERENCE">Mahadevan 1983</LINK>). Since the late 1980s several assisted fertilisation techniques have emerged and have been rapidly developed to try to enhance results for couples with male factor subfertility, or to help couples with severe male factor for whom conventional IVF was not possible. Although such techniques do not address the basic sperm defect they allow such couples a chance to conceive, without having to resort to insemination with donor sperm, since a much smaller number of spermatozoa are required. A second group of couples for whom such techniques are used are those with normal semen parameters but where conventional IVF has led to (repeated) poor or failed fertilisation due to defective sperm-oocyte interaction. Intra-cytoplasmatic sperm injection (ICSI) is such a technique. ICSI could be used in couples with unexplained subfertility as well. We question whether IVF-ICSI might improve livebirth rates or pregnancy rates in couples with unexplained infertility as compared to IVF alone.</P>
</CONDITION>
<INTERVENTION MODIFIED="2011-05-16 21:59:18 +1000" MODIFIED_BY="[Empty name]">
<P>Several micromanipulation techniques, progressively more invasive towards the oocyte, have been tried to overcome the zona pellucida barrier between spermatozoon and oocyte and so to increase the probability that a sperm capable of fertilisation comes in contact with the oocyte. Previous treatments consisted of partial zona dissection (PZD) (<LINK REF="REF-Malter-1989" TYPE="REFERENCE">Malter 1989</LINK>) and subzonal microinjection of spermatozoa into the perivitelline space (SUZI) (<LINK REF="REF-Laws_x002d_King-1987" TYPE="REFERENCE">Laws-King 1987</LINK>). However, for these techniques the fertilisation rates remained low, rates of polyspermic fertilisation were increased, and cases with a very limited number of spermatozoa in the ejaculate could still not be treated. PZD and SUZI were abandoned both in the clinic and in research after the introduction of ICSI (<LINK REF="REF-Palermo-1992" TYPE="REFERENCE">Palermo 1992</LINK>).</P>
<P>For ICSI, a single spermatozoon is injected centrally into the cytoplasm of the oocyte using a fine sharp tipped glass pipette. The procedure consists of two essential components that are completed within two to four minutes per oocyte. Firstly, a selected sperm is stunned by one of several commonly used techniques such as rubbing the tail with the injection pipette or abruptly aspirating the sperm into the pipette. The sperm is aspirated tail first into the injection pipette and positioned at three o'clock near the oocyte. A suction pipette stabilises the oocyte with the polar body at either the six o'clock or twelve o'clock position as the pipette is inserted. Secondly, the cytoplasm is drawn up into the pipette to ensure the cytoplasmic membrane is broken thus allowing successful insertion of the sperm. The pipette is subsequently withdrawn from the egg.</P>
<P>In the case of conventional IVF one oocyte is inseminated with approximately 50,000 spermatozoa.</P>
</INTERVENTION>
<THEORY MODIFIED="2011-05-16 22:00:14 +1000" MODIFIED_BY="[Empty name]">
<P>ICSI has proven to be the therapy of choice for couples with severe male factor infertility in whom IVF is not an option (<LINK REF="REF-Palermo-1995" TYPE="REFERENCE">Palermo 1995</LINK>). Since the zona pellucida barrier is overcome with ICSI, the technique might improve the outcome in couples with non-male factor subfertility as well.</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-05-16 22:21:55 +1000" MODIFIED_BY="[Empty name]">
<P>For the couples involved the main goal of the assisted fertilisation techniques is for them to have a normal and healthy baby. Because ICSI is a fairly new technique, the children born after ICSI have been closely followed-up. There are concerns about the effect of using an abnormal spermatozoa. The incidence of major malformations is approximately 3% to 4% , which is within the range observed in the general population (<LINK REF="REF-Bonduelle-2002" TYPE="REFERENCE">Bonduelle 2002</LINK>; <LINK REF="REF-Palermo-2000" TYPE="REFERENCE">Palermo 2000</LINK>; <LINK REF="REF-Van-Steirteghem-1998" TYPE="REFERENCE">Van Steirteghem 1998</LINK>). <LINK REF="REF-Hansen-2002" TYPE="REFERENCE">Hansen 2002</LINK> found major birth defects in 9% of children born after ICSI but the same risk after conventional IVF; so twice as high a risk but independent of the technique used for in vitro fertilisation. The de-novo sex chromosomal aneuploidy and structural autosomal abnormalities are slightly but significantly increased in children born after ICSI (<LINK REF="REF-te-Velde-1998" TYPE="REFERENCE">te Velde 1998</LINK>; <LINK REF="REF-Van-Steirteghem-2002" TYPE="REFERENCE">Van Steirteghem 2002</LINK>). Within children born after ICSI there is also an increased number of inherited (mostly from the father's side) aberrations in comparison with a general neonatal population (<LINK REF="REF-Van-Steirteghem-2002" TYPE="REFERENCE">Van Steirteghem 2002</LINK>). Males are more affected than females. For the couples involved, conceiving a child who is genetically their own appears to outweigh other considerations (<LINK REF="REF-de-Wert-1998" TYPE="REFERENCE">de Wert 1998</LINK>).</P>
<P>This review aimed to investigate whether, and to what extent, ICSI improved live birth rates or pregnancy rates compared to the technique of conventional IVF in couples with non-male subfertility.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To determine the effect of ICSI relative to IVF for couples with non-male factor subfertility.</P>
</OBJECTIVES>
<METHODS MODIFIED="2011-05-16 22:18:39 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-05-16 22:08:43 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomised controlled trials investigating ICSI versus conventional IVF were included in this trial. The unit of randomisation was couples. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-05-16 22:07:50 +1000" MODIFIED_BY="[Empty name]">
<P>Couples with non-male factor subfertility were included in this review, that is couples with unexplained subfertility, or subfertility due to tubal disease, who were enrolled in an in vitro fertilisation program.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-05-16 22:08:28 +1000" MODIFIED_BY="[Empty name]">
<P>The comparison of Intra-cytoplasmic sperm injection (ICSI) versus in vitro fertilisation (IVF) was analysed.<BR/>
</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-05-16 22:08:43 +1000" MODIFIED_BY="[Empty name]">
<P>The following outcomes were stated, where possible.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-05-16 22:08:43 +1000" MODIFIED_BY="[Empty name]">
<P>1. Live birth rate (per couple)</P>
<P>2. Adverse events (per couple)</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-08-11 10:14:08 +1000" MODIFIED_BY="[Empty name]">
<P>1. Pregnancy rate (per couple)<BR/>2. Miscarriage rate (per pregnancy)</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-05-16 22:13:44 +1000" MODIFIED_BY="[Empty name]">
<P>The Cochrane Menstrual Disorders and Subfertility Group Trials Register was searched using the following key words Title CONTAINS "ICSI" or "intracytoplasmic morphologically selected sperm injection" or "intracytoplasmic sperm injection" AND Title CONTAINS "IVF" or "IVF-ET" or "in-vitro fertilisation" or "in vitro fertilization" (updated August 2010). The Cochrane Central Register of Controlled (CENTRAL) (<I>The Cochrane Library</I> 2002, Issue 2), PubMed (January 1992 to July 2002) and reference lists of articles were searched. These searches were re-run for the update of the review (August 2010).</P>
<ELECTRONIC_SEARCHES MODIFIED="2011-05-16 22:13:02 +1000" MODIFIED_BY="[Empty name]">
<P>The following electronic sources were searched in the update of this review (August 2010): PsycINFO (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>); CENTRAL (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>); MEDLINE (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>); EMBASE (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2011-05-16 22:13:44 +1000" MODIFIED_BY="[Empty name]">
<P>The reference lists of retrieved articles were handsearched for additional material and personal contact was made with content experts if required.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-05-16 22:18:39 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2011-01-18 11:20:37 +1100" MODIFIED_BY="Julie A Brown">
<P>Two review authors (MR and JE) scanned the titles and abstracts of the identified studies. Those that were clearly irrelevant were excluded. The full text of potentially relevant articles were retrieved and independently assessed for inclusion by MR and JE. Disagreement was resolved by consensus.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-05-16 22:14:38 +1000" MODIFIED_BY="[Empty name]">
<P>The review authors independently extracted data. Disagreements were resolved by consensus. Where studies had multiple publications, the main trial was used as the reference and additional details were obtained from the supplementary references. Authors of original papers were contacted if additional information was required.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-05-16 22:15:31 +1000" MODIFIED_BY="[Empty name]">
<P>The included studies were assessed for risk of bias using the Cochrane 'risk of bias' assessment tool (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) to assess sequence generation, allocation concealment, blinding (participant, providers, outcome assessors), completeness of outcome data and selective reporting. Two review authors assessed these domains and disagreements were resolved by consensus. A summary can also be referred to in the 'Risk of bias' table (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-05-16 22:16:32 +1000" MODIFIED_BY="[Empty name]">
<P>The dichotomous results for each study were expressed as an odds ratio with 95% confidence interval. These results were combined for meta-analysis with RevMan software (using the Mantel-Haenszel method) in a fixed-effect model. No continuous data were anticipated.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2011-05-16 22:16:50 +1000" MODIFIED_BY="[Empty name]">
<P>Per cycle data were not included in the meta-analysis. Original authors were contacted and requested to provide per woman data, if possible.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-05-16 22:16:57 +1000" MODIFIED_BY="[Empty name]">
<P>Where data were missing, the original authors were contacted. Where attrition of the participants in a trial exceeded 20% of the sample a sensitivity analysis would have been conducted.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-05-16 22:17:38 +1000" MODIFIED_BY="[Empty name]">
<P>Statistical heterogeneity was to be assessed using the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). If heterogeneity had exceeded 20% then sensitivity analysis would have been conducted in an attempt to explain the data. Where heterogeneity could not be adequately explained the data would not have been pooled in a meta-analysis.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2011-05-16 22:17:50 +1000" MODIFIED_BY="[Empty name]">
<P>Where eight or more studies were identified, a funnel plot would be produced to investigate reporting bias.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-05-16 22:18:13 +1000" MODIFIED_BY="[Empty name]">
<P>For dichotomous data a Mantel-Haenszel method was to be used with a fixed-effect model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-01-18 12:10:50 +1100" MODIFIED_BY="Julie A Brown">
<P>There were no pre-specified subgroups in this review.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-05-16 22:18:39 +1000" MODIFIED_BY="[Empty name]">
<P>If heterogeneity exceeded 50% then a sensitivity analysis would have been conducted based on the quality components of the risk of bias.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-05-16 22:27:11 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2011-05-16 22:25:21 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2010-08-18 13:01:46 +1000" MODIFIED_BY="[Empty name]">
<P>We identified 15 controlled trials that evaluated the use of ICSI in comparison with an alternative method.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2011-05-16 22:19:42 +1000" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>
<BR/>One study (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>) that randomised couples to either treatment, using a centralised telephone system, was included in the review.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2011-05-16 22:25:21 +1000" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>
<BR/>Eight studies were excluded because they randomised oocytes instead of couples (<LINK REF="STD-Aboulghar-1995" TYPE="STUDY">Aboulghar 1995</LINK>; <LINK REF="STD-Aboulghar-1996a" TYPE="STUDY">Aboulghar 1996a</LINK>; <LINK REF="STD-Calderon-1995" TYPE="STUDY">Calderon 1995</LINK>; <LINK REF="STD-Catt-1995" TYPE="STUDY">Catt 1995</LINK>; <LINK REF="STD-Kastrop-1999" TYPE="STUDY">Kastrop 1999</LINK>; <LINK REF="STD-Payne-1997" TYPE="STUDY">Payne 1997</LINK>; <LINK REF="STD-Staessen-1998" TYPE="STUDY">Staessen 1998</LINK>; <LINK REF="STD-Yang-1996" TYPE="STUDY">Yang 1996</LINK>).</P>
<P>Three studies were excluded because they used non-random methods (for example alternation) to allocate participants to either treatment group (<LINK REF="STD-Aboulghar-1996b" TYPE="STUDY">Aboulghar 1996b</LINK>; <LINK REF="STD-Bukulmez-2000" TYPE="STUDY">Bukulmez 2000</LINK>; <LINK REF="STD-Ruiz-1997" TYPE="STUDY">Ruiz 1997</LINK>). One study (<LINK REF="STD-Moreno-1998" TYPE="STUDY">Moreno 1998</LINK>) was excluded as it was not clear if it was a randomised study and the numbers of participants were not stated. <LINK REF="STD-Clasen-1996" TYPE="STUDY">Clasen 1996</LINK> was excluded because the study was a pilot study with fertilisation as the endpoint. This study was never continued. <LINK REF="STD-Levran-1995" TYPE="STUDY">Levran 1995</LINK>, which was included in the previous review, compared ICSI with SUZI and not IVF and was therefore excluded.</P>
<SUBSECTION>
<HEADING LEVEL="5">Studies awaiting assessment</HEADING>
<P>See <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>
<BR/>One study is still awaiting assessment (<LINK REF="STD-Poehl-2001" TYPE="STUDY">Poehl 2001</LINK>) as the method of randomisation is unclear and the outcomes are only reported as percentages. The authors have been written to for further information but we have not received a response as yet.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-05-16 22:26:23 +1000" MODIFIED_BY="[Empty name]">
<P>In the included study (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>) the risk of bias was low since couples were randomly allocated by a centralised system.</P>
<ALLOCATION MODIFIED="2011-01-24 08:33:01 +1100" MODIFIED_BY="Julie A Brown">
<P>The allocation method was clear in the one included study (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>). The couples were randomised by means of a centralised telephone system. Stratification was performed by centre and there was minimisation of key prognostic variables including age, parity and previous treatment with IVF.</P>
</ALLOCATION>
<BLINDING MODIFIED="2011-01-24 08:34:36 +1100" MODIFIED_BY="Julie A Brown">
<P>
<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK> did not state any details on blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2011-01-24 08:37:03 +1100" MODIFIED_BY="Julie A Brown">
<P>Data were originally presented as per cycle (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>) and attrition was documented throughout the trial. The review authors were able to obtain per couple data from the original author.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-01-24 08:37:54 +1100" MODIFIED_BY="Julie A Brown">
<P>All a priori outcomes were reported in the paper (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2011-05-16 22:26:23 +1000" MODIFIED_BY="[Empty name]">
<P>The review is based on a single included study (<LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>), with the sample population being from the United Kingdom only.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-05-16 22:27:11 +1000" MODIFIED_BY="[Empty name]">
<P>From the trial of <LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK> we can conclude there is no evidence of difference between ICSI and IVF for couples with non-male subfertility on pregnancy rates (OR 1.44, 95% CI 0.95 to 2.21). The other data on multiple pregnancy rates and fertilisation rates were presented as per cycle data and were therefore not included in this review.</P>
<P>Adverse events were not stated.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-05-16 22:37:01 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2011-05-16 22:31:45 +1000" MODIFIED_BY="[Empty name]">
<P>ICSI is a technique already used worldwide to treat couples with male factor fertility problems. The first intra-cytoplasmic injection was described by <LINK REF="REF-Palermo-1992" TYPE="REFERENCE">Palermo 1992</LINK>. This technique rapidly became incorporated into assisted reproductive technologies for couples with severe male factor infertility. ICSI surpassed SUZI as the method of choice. Most assisted reproduction technology (ART) clinics report a fertilisation percentage for ICSI of 70% (<LINK REF="REF-Abdelmassih-1998" TYPE="REFERENCE">Abdelmassih 1998</LINK>; <LINK REF="REF-Tarlatzis-1998" TYPE="REFERENCE">Tarlatzis 1998</LINK>; <LINK REF="REF-Van-Steirteghem-1998" TYPE="REFERENCE">Van Steirteghem 1998</LINK>).</P>
<P>In the study of <LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>, 20 couples had a cycle which was randomised twice after failure to conceive the first time. We received the data excluding these 20 cycles and the results on the pregnancy rate were the same.</P>
<P>In the ICSI group there were 51 ongoing pregnancies in the 202 couples randomised, compared to 70 for the 213 couples in the IVF group (OR 1.44, 95% CI 0.95 to 2.21) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2011-05-16 22:32:18 +1000" MODIFIED_BY="[Empty name]">
<P>The review was based on a single trial. Those trials that were excluded reported randomisation per cycle data only. There was a lack of data on live birth rate, miscarriage rates and adverse events, which limits the generalisabilty of the findings.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2011-01-24 09:28:56 +1100" MODIFIED_BY="Julie A Brown">
<P>This was a single trial of 415 couples in the United Kingdom. The design was considered robust with the exception of the lack of clarity on blinding.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2011-05-02 09:26:13 +1000" MODIFIED_BY="[Empty name]">
<P>The main bias is that the review is based on a single trial, with a population from a single country. </P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-05-16 22:37:01 +1000" MODIFIED_BY="[Empty name]">
<P>Two studies (<LINK REF="STD-Aboulghar-1996b" TYPE="STUDY">Aboulghar 1996b</LINK>; <LINK REF="STD-Bukulmez-2000" TYPE="STUDY">Bukulmez 2000</LINK>) compared ICSI with IVF and had couples as the unit of comparison. They used alternation to allocate couple, so there was no randomisation. In spite of this, we have described these studies here, but we will not base our conclusions on these results. Both studies included couples with normal semen. The general characteristics were comparable for the couples in the ICSI and IVF groups. The mean duration of infertility was quite long, in <LINK REF="STD-Bukulmez-2000" TYPE="STUDY">Bukulmez 2000</LINK> it was nine to 10 years and in <LINK REF="STD-Aboulghar-1996b" TYPE="STUDY">Aboulghar 1996b</LINK> it was seven to eight years. Approximately three embryos were transferred per cycle. In <LINK REF="STD-Aboulghar-1996b" TYPE="STUDY">Aboulghar 1996b</LINK> 116 couples were included, and 76 couples in <LINK REF="STD-Bukulmez-2000" TYPE="STUDY">Bukulmez 2000</LINK>, which gives a total of 192 couples. The fertilisation rate per oocyte retrieved was significantly higher in the IVF group. In the IVF group 477 of the 736 retrieved oocytes fertilised, compared to 400 of 748 in the ICSI group. This results in an OR of 1.60 (95% CI 1.30 to 1.96). There was no difference in the pregnancy rate (OR 0.95, 95% CI 0.51 to 1.78; ICSI: 27/96, IVF: 26/96). Neither was there a difference in the miscarriage rate (OR 0.76, 95% CI 0.15 to 3.84; ICSI: 4/19, IVF: 3/18), nor in live birth rate (OR 0.83, 95% CI 0.25 to 2.73; ICSI: 7/38, IVF: 6/38). In conclusion, there is no statistical difference between ICSI or IVF for conceiving a child within the couples concerned.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-05-16 22:39:11 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-05-16 22:38:35 +1000" MODIFIED_BY="[Empty name]">
<P>ICSI is more costly and more complex than IVF. There are concerns about ICSI regarding adverse events and long term complications. Therefore, for couples with non-male factor subfertility who qualify for assisted reproduction IVF, and not ICSI, is the treatment of choice.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-05-16 22:39:11 +1000" MODIFIED_BY="[Empty name]">
<P>More studies need to be done comparing ICSI with IVF in non-male factor subfertility. It is important that they are randomised in a methodologically rigorous way. Couples should be the unit of randomisation if the study is to have any implication for clinical practice. Long term follow-up studies should report on live births, birth defects and child development as outcome measures.<BR/>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-05-16 22:41:15 +1000" MODIFIED_BY="[Empty name]">
<P>The authors are indebted to Julie Brown (Cochrane Menstrual Disorders and Subfertility Group (MDSG)), Tracy Naysmith (Fertility Plus, Auckland), Anne Lethaby, Sarah Hetrick (former MDSGroup Co-ordinator), Michelle Proctor (MDSG Co-ordinator), Sue Furness (former MDSG Trials Search Co-ordinator) and Ruth Withers (Trials Search Co-ordinator) for assistance with this review.</P>
<P>The authors are especially grateful to the following trialists who provided additional material for this review: Dr Aboulghar, Dr Bhattacharya, Dr Clasen, Dr Calderon, Dr Hamilton, Dr Kastrop, Dr Moreno and Dr Ruiz.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-05-16 22:41:36 +1000" MODIFIED_BY="[Empty name]">
<P>M van Rumste: took the lead in writing the protocol and review, performed searches of databases for trials, was involved in selecting trials for inclusion, performed independent data extraction and quality assessment of the included trials, was responsible for statistical analysis and interpretation of the data.</P>
<P>Professor Evers: performed independent data extraction and quality assessment of the included trials, added clinical expertise to the review.</P>
<P>Professor Farquhar: commented on drafts of the review and added clinical expertise to the review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-05-16 22:42:08 +1000" MODIFIED_BY="[Empty name]">
<P>Adverse events were added as a primary outcome as they were discussed in the text of the review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2011-05-16 22:42:53 +1000" MODIFIED_BY="[Empty name]">
<P>Since ICSI has proven to be the therapy of choice for couples with severe male factor infertility in whom IVF is not possible, the comparison has been narrowed down to ICSI versus IVF in couples with non-male factor subfertility.</P>
<P>ICSI has by far surpassed PZD and SUZI, therefore the title has been changed from "Inta-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation" to "ICSI versus IVF in couples with non-male subfertility".</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-05-16 22:58:02 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2011-05-16 22:54:03 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2011-05-16 22:47:18 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bhattacharya-2001" MODIFIED="2011-05-16 22:47:18 +1000" MODIFIED_BY="[Empty name]" NAME="Bhattacharya 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bhattacharya S, Hamilton M, Shaaban M, Khalaf Y, Seddler M, Ghobara T et al</AU>
<TI>Conventional in vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>Jun 30</NO>
<PG>2075-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID: 11445099"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-05-16 22:47:18 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton M, Shaaban M, Bhattacharya S, Odit R, Ghobara T, Khalaf Y et al</AU>
<TI>IVF vs ICSI in non-male factor infertility: a multicentre prospective randomised controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>1998</YR>
<VL>70 Suppl 3</VL>
<PG>Abstr O-252</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-05-16 22:52:49 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Aboulghar-1995" NAME="Aboulghar 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aboulghar MA, Mansour RT, Serour GI, Amin YM</AU>
<TI>The role of intracytoplasmic sperm injection (ICSI) in the treatment of patients with borderline semen</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>11</VL>
<PG>2829-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aboulghar-1996a" MODIFIED="2011-05-16 22:49:26 +1000" MODIFIED_BY="[Empty name]" NAME="Aboulghar 1996a" YEAR="1996">
<REFERENCE MODIFIED="2011-05-16 22:49:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Amin YM</AU>
<TI>Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1996</YR>
<VL>1</VL>
<PG>38-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aboulghar-1996b" MODIFIED="2011-05-16 22:49:59 +1000" MODIFIED_BY="[Empty name]" NAME="Aboulghar 1996b" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Aboulghar M, Mansour R, Serour I</AU>
<TI>A controlled prospective randomized study between ICSI and IVF in tubal factor inferility with normal semen</TI>
<SO>Abstracts of the 12th Annual Meeting of European Society of Human Reproduction and Embrology (ESHRE)</SO>
<YR>1996</YR>
<VL>38</VL>
<PG>080</PG>
<PB>Oxford University Press</PB>
<CY>Maastricht</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-05-16 22:49:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aboulghar MA, Amin YM, Mansour RT, Kamal A, Serour GI</AU>
<TI>Prospective controlled randomized study of in vitro fertilization versus intracytoplasic sperm injection in the treatment of tubal factor infertility with normal semen parameters</TI>
<SO>Fertility and Sterility</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>753-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bukulmez-2000" MODIFIED="2011-05-16 22:50:21 +1000" MODIFIED_BY="[Empty name]" NAME="Bukulmez 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-05-16 22:50:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bukulmez O, Yarali H, Yucel A, Sari T, Gurgan T</AU>
<TI>Intracytoplasmic sperm injection versus in vitro fertilisation for patients with a tubal factor as their sole cause of infertility: a prospective, randomized trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2000</YR>
<VL>73</VL>
<NO>1</NO>
<PG>38-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Calderon-1995" MODIFIED="2011-05-16 22:50:48 +1000" MODIFIED_BY="[Empty name]" NAME="Calderon 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-05-16 22:50:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Calderon G, Belil I, Aran B, Veiga A, Gil Y, Boada M et al</AU>
<TI>Intracytoplasmic sperm injection versus conventional in-vitro fertilization: first results</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>10</VL>
<PG>2835-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Catt-1995" MODIFIED="2011-05-16 22:51:04 +1000" MODIFIED_BY="[Empty name]" NAME="Catt 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-05-16 22:51:04 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Catt J, Ryan J, Pike I, O'Neill C</AU>
<TI>Fertilization rates using intracytoplasmic sperm injection are greater than subzonal insemination but are dependent on prior treatment of sperm</TI>
<SO>Fertility and Sterility</SO>
<YR>1995</YR>
<VL>64</VL>
<PG>764-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clasen-1996" NAME="Clasen 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Clasen K, Van Eeckhout E, Tournaye H, Van Steirteghem AC, Devroey P</AU>
<TI>Moderate male factor infertility: IVF or ICSI?</TI>
<SO>Abstracts of the 12th Annual Meeting of European Society of Human Reproduction and Embrology (ESHRE)</SO>
<YR>1996</YR>
<VL>T018</VL>
<PG>194</PG>
<PB>Oxford University Press</PB>
<CY>Maastricht</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kastrop-1999" NAME="Kastrop 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kastrop PMM, Van Kooije RJ, Te Velde ER</AU>
<TI>Comparison between ICSI and IVF with a high insemination concentration after total fertilization failure in a previous IVF attempt</TI>
<SO>Abstracts of the 12th Annual Meeting of European Society of Human Reproduction and Embrology (ESHRE)</SO>
<YR>1996</YR>
<VL>P060</VL>
<PG>124</PG>
<PB>Oxford University Press</PB>
<CY>Maastricht</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kastrop PMM, Weima SM, Van Kooij RJ, Te Velde ER</AU>
<TI>Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>65-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levran-1995" MODIFIED="2011-05-16 22:51:47 +1000" MODIFIED_BY="[Empty name]" NAME="Levran 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-05-16 22:51:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levran D, Bider D, Yonesh M, Yemini Z, Seidman DS, Mashiach S et al</AU>
<TI>A randomized study of intracytoplasmic sperm injection (ICSI) versus subzonal insemination (SUZI) for the managment of severe male-factor infertility</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1995</YR>
<VL>12</VL>
<PG>319-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moreno-1998" MODIFIED="2011-05-16 22:52:01 +1000" MODIFIED_BY="[Empty name]" NAME="Moreno 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-05-16 22:52:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreno C, Ruiz A, Simon C, Pellicer A, Remohi J</AU>
<TI>Intracytoplasmic sperm injection as a routine indication in low responder patients</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>8</NO>
<PG>2126-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Payne-1997" NAME="Payne 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Payne D, Flaherty SP, Matthews CD</AU>
<TI>A prospective controlled trial of ICSI versus IVF for the treatment of teratozoospermia</TI>
<SO>The Fertility Society of Australia: XVI Annual Scientific Meeting Programme and Abstract Book</SO>
<YR>1997</YR>
<VL>O-36</VL>
<PG>56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruiz-1997" MODIFIED="2011-05-16 22:52:23 +1000" MODIFIED_BY="[Empty name]" NAME="Ruiz 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-05-16 22:52:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ruiz A, Guanes PP, Remohi J, Simon C, Minguez Y, Pellicer A</AU>
<TI>The role of in vitro fertilization and intracytoplasmic sperm injection in couples with unexplained infertility after failed intrauterine insemination</TI>
<SO>Fertility and Sterility</SO>
<YR>1997</YR>
<VL>68</VL>
<PG>171-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Staessen-1998" NAME="Staessen 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A</AU>
<TI>Conventional IVF versus ICSI in sibling oocytes for non-male indications</TI>
<SO>Abstracts of the 12th Annual Meeting of European Society of Human Reproduction and Embrology (ESHRE)</SO>
<YR>1998</YR>
<VL>O-179</VL>
<PG>90</PG>
<CY>Goteborg</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-1996" MODIFIED="2011-05-16 22:52:49 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-05-16 22:52:49 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang D, Shahata MZ, Al-Bader M, Al-Natscha SD, Al-Flamerzia M, Al-Shawaf T</AU>
<TI>Intracytoplasmic sperm injection improving embryo quality: Comparison of the sibling oocytes of non-male-factor couples</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1996</YR>
<VL>4</VL>
<PG>351-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-05-16 22:54:03 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Poehl-2001" MODIFIED="2011-05-16 22:54:03 +1000" MODIFIED_BY="[Empty name]" NAME="Poehl 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-05-16 22:53:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Poehl M, Bichler K, Krischker U, Feichtinger W, Jurgen S</AU>
<TI>In vitro fertilization in cases without male factor infertility: "To ICSI" or "Not to ICSI" - That's the question</TI>
<SO>Fertility and Sterility</SO>
<YR>1998</YR>
<VL>70 Suppl 3</VL>
<PG>Abstr O-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-05-16 22:54:03 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poehl M, Holagschwandtner M, Bichler K, Krischker U, Jurgen S, Feichtinger W</AU>
<TI>IVF-Patients with nonmale factor "To ICSI" or "Not to ICSI" That is the question?</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>4</NO>
<PG>205-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-05-16 22:58:02 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2011-05-16 22:58:02 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abdelmassih-1998" NAME="Abdelmassih 1998" TYPE="CONFERENCE_PROC">
<AU>Abdelmassih S, Abdelmassih V, Abdelmassih R, Salgueiro L, Oliveira F, Balmaceda J</AU>
<TI>A prospective randomized study of pregnancy and implantation rates with ICSI: 48 versus 72 h embryo transfers</TI>
<SO>Abstracts of the 12th Annual Meeting of European Society of Human Reproduction and Embrology (ESHRE)</SO>
<YR>1998</YR>
<VL>O-096</VL>
<PG>47</PG>
<CY>Goteborg</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Acosta-1986" NAME="Acosta 1986" TYPE="JOURNAL_ARTICLE">
<AU>Acosta AA, Chillik CF, Brugo S, Ackerman S, Swanson RJ, Pleban P et al</AU>
<TI>In vitro fertilization and the male factor</TI>
<SO>Urology</SO>
<YR>1986</YR>
<VL>28</VL>
<NO>1</NO>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bonduelle-2002" NAME="Bonduelle 2002" TYPE="JOURNAL_ARTICLE">
<AU>Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P et al</AU>
<TI>Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999)</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>3</NO>
<PG>671-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Wert-1998" MODIFIED="2011-05-16 22:54:50 +1000" MODIFIED_BY="[Empty name]" NAME="de Wert 1998" TYPE="JOURNAL_ARTICLE">
<AU>de Wert G</AU>
<TI>Ethics of intracytoplasmic sperm injection: proceed with care</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13 Suppl 1</VL>
<PG>219-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hansen-2002" NAME="Hansen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Hansen M, Kurinczuk JJ, Bower C, Webb S</AU>
<TI>The risk of major birth defects after intracytoplasmic sperm injection and in vitro ferilization</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>10</NO>
<PG>725-30</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID: 11882727"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2011-05-16 22:55:10 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S, editors</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<EN>Version 5.0.2 [updated September 2009]. Available from www.cochrane-handbook.org.</EN>
<ED>Higgins JPT, Green S</ED>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lanzendorf-1988" MODIFIED="2011-05-16 22:55:53 +1000" MODIFIED_BY="[Empty name]" NAME="Lanzendorf 1988" TYPE="JOURNAL_ARTICLE">
<AU>Lanzendorf SE, Maloney MK, Veeck LL, Slusser J, Hodgen GD, Rosenwaks Z</AU>
<TI>A preclinical evaluation of pronuclear formation by microinjection of human spermatozoa into human oocytes</TI>
<SO>Fertility and Sterility</SO>
<YR>1988</YR>
<VL>49</VL>
<NO>5</NO>
<PG>835-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laws_x002d_King-1987" MODIFIED="2011-05-16 22:56:11 +1000" MODIFIED_BY="[Empty name]" NAME="Laws-King 1987" TYPE="JOURNAL_ARTICLE">
<AU>Laws-King A, Trounson A, Sathananthan AH, Kola I</AU>
<TI>Fertilisation of human oocytes by micro-injection of a single spermatozooan under the zona pellucida</TI>
<SO>Fertility and Sterility</SO>
<YR>1987</YR>
<VL>48</VL>
<PG>637-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mahadevan-1983" MODIFIED="2011-05-16 22:56:27 +1000" MODIFIED_BY="[Empty name]" NAME="Mahadevan 1983" TYPE="JOURNAL_ARTICLE">
<AU>Mahadevan MM, Trounson AO, Leeton JF</AU>
<TI>The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>1983</YR>
<VL>40</VL>
<NO>6</NO>
<PG>755-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malter-1989" MODIFIED="2011-05-16 22:56:45 +1000" MODIFIED_BY="[Empty name]" NAME="Malter 1989" TYPE="JOURNAL_ARTICLE">
<AU>Malter HE, Cohen J</AU>
<TI>Partial zona dissection of the human oocyte: a nontraumatic method using micromanipulation to assist zona pellucida penetration</TI>
<SO>Fertility and Sterility</SO>
<YR>1989</YR>
<VL>51</VL>
<NO>1</NO>
<PG>139-48</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID 2910709"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Palermo-1992" MODIFIED="2011-05-16 22:57:01 +1000" MODIFIED_BY="[Empty name]" NAME="Palermo 1992" TYPE="JOURNAL_ARTICLE">
<AU>Palermo G, Joris H, Devroey P, Van Steirteghem A</AU>
<TI>Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>340</VL>
<PG>17-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Palermo-1995" MODIFIED="2011-05-16 22:57:21 +1000" MODIFIED_BY="[Empty name]" NAME="Palermo 1995" TYPE="JOURNAL_ARTICLE">
<AU>Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z</AU>
<TI>Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility</TI>
<SO>Fertility and Sterility</SO>
<YR>1995</YR>
<VL>63</VL>
<NO>6</NO>
<PG>1231-40</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID: 7750593"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Palermo-2000" NAME="Palermo 2000" TYPE="JOURNAL_ARTICLE">
<AU>Palermo GD, Neri QV, Hariprashad JJ, Davis OK, Veeck LL, Rosenwaks Z</AU>
<TI>ICSI and its outcome</TI>
<SO>Seminars in Reproductive Medicine</SO>
<YR>2000</YR>
<VL>18</VL>
<NO>2</NO>
<PG>161-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tarlatzis-1998" NAME="Tarlatzis 1998" TYPE="JOURNAL_ARTICLE">
<AU>Tarlatzis B, Bili H</AU>
<TI>Survey on intracytoplasmic sperm injection: report from the ESHRE ICSI Task Force</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>S1</NO>
<PG>165-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-te-Velde-1998" MODIFIED="2011-05-16 22:57:46 +1000" MODIFIED_BY="[Empty name]" NAME="te Velde 1998" TYPE="JOURNAL_ARTICLE">
<AU>te Velde E, van Baar A, van Kooije R</AU>
<TI>Concerns about assisted reproduction</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<PG>1524-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Steirteghem-1998" MODIFIED="2011-05-16 22:58:02 +1000" MODIFIED_BY="[Empty name]" NAME="Van Steirteghem 1998" TYPE="JOURNAL_ARTICLE">
<AU>Van Steirteghem A, Nagy P, Joris H, Janssenswillen C, Staessen C, Verheyen G et al</AU>
<TI>Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>S1</NO>
<PG>134-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Steirteghem-2002" NAME="Van Steirteghem 2002" TYPE="JOURNAL_ARTICLE">
<AU>Van Steirteghem A, Bonduelle M, Devroey P, Liebaers I</AU>
<TI>Follow-up of children born after ICSI</TI>
<SO>Human Reproduction Update</SO>
<YR>2002</YR>
<VL>8</VL>
<NO>2</NO>
<PG>111-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID: 12099626"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-05-16 22:45:18 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-05-16 22:44:15 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-05-16 22:43:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhattacharya-2001">
<CHAR_METHODS>
<P>After informed consent, couples were randomly assigned to an IVF or an ICSI treatment cycle by means of a centralised telephone system.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-16 22:43:24 +1000" MODIFIED_BY="[Empty name]">
<P>Couples awaiting IVF for an indication other than severe male-factor infertility. Women younger than 37 years. Semen acceptable for IVF.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>ICSI versus IVF</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-16 22:43:42 +1000" MODIFIED_BY="[Empty name]">
<P>Pregnancy rate<BR/>Fertilisation rate </P>
<P>Implantation rate<BR/>Total fertilisation failure rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-16 22:43:57 +1000" MODIFIED_BY="[Empty name]">
<P>20 couples were recruited to the trial for a second time after failure to achieve pregnancy with the first cycle of treatment and were re-randomised.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>Extra information was provided by Dr Hamilton.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-05-16 22:45:18 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aboulghar-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Aboulghar-1996a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Aboulghar-1996b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not random. Alternation was used to allocate patients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bukulmez-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not random. Alternation was used to allocate patients after oocyte retrieval by one of the authors.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Calderon-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Catt-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Clasen-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was a pilot study which was never continued. Fertilisation was the endpoint.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kastrop-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation. This was a comparison of ICSI versus additional IVF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Levran-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Comparison of ICSI versus SUZI, not IVF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moreno-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Method of randomisation was not stated. Even after contact with one of the authors randomisation could not be clarified. Data was presented in percentages and not the actual numbers. These numbers were not available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-16 22:45:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Payne-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-16 22:45:18 +1000" MODIFIED_BY="[Empty name]">
<P>No randomisation. The oocytes were pooled in order of retrieval. The first group of 4 oocytes went to the ICSI group. The second group (05-08) went to IVF. The third group (09-12) went to ICSI, and so on.<BR/>The minimum number of oocytes in the IVF group is 4 and the maximum is 6 and in some cases 8. The rest of the oocytes were given ICSI. The mature state of the oocytes was also taken into consideration. If there were not enough mature oocytes, the first mature oocytes starting with group 2 were allocated to the IVF group.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ruiz-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>No randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Staessen-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yang-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Couples were not the unit of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>Extra information was provided by Aboulghar, Clasen, Calderon, Kastrop, Moreno and Ruiz.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-01-24 09:09:38 +1100" MODIFIED_BY="Julie A Brown" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2011-01-24 09:09:38 +1100" MODIFIED_BY="Julie A Brown" STUDY_ID="STD-Poehl-2001">
<CHAR_METHODS MODIFIED="2011-01-24 09:08:26 +1100" MODIFIED_BY="Julie A Brown">
<P>Method of randomisation unclear. No blinding</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-24 09:08:49 +1100" MODIFIED_BY="Julie A Brown">
<P>N=91 patients with tubal infertility or hostile cervical mucus</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-24 09:09:03 +1100" MODIFIED_BY="Julie A Brown">
<P>n=44 ICSI; n=45 IVF</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-24 09:09:38 +1100" MODIFIED_BY="Julie A Brown">
<P>Pregnancy rate; ongoing pregnancy rate; implantation rate per transferred embryo</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-05-02 09:21:22 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-01-24 09:02:29 +1100" MODIFIED_BY="Julie A Brown" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 09:02:29 +1100" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Bhattacharya-2001">
<DESCRIPTION>
<P>'randomly'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-05-02 09:21:22 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-02 09:21:22 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhattacharya-2001">
<DESCRIPTION>
<P>Adequate, centralised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-01-24 09:02:41 +1100" MODIFIED_BY="Julie A Brown" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-24 09:02:41 +1100" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Bhattacharya-2001">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-01-24 09:03:06 +1100" MODIFIED_BY="Julie A Brown" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-24 09:03:06 +1100" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Bhattacharya-2001">
<DESCRIPTION>
<P>Attrition (per cycle) is documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-01-24 09:03:22 +1100" MODIFIED_BY="Julie A Brown" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 09:03:22 +1100" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Bhattacharya-2001">
<DESCRIPTION>
<P>A priori outcomes are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-01-24 09:03:30 +1100" MODIFIED_BY="Julie A Brown" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-05-16 22:46:32 +1000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2011-05-16 22:46:32 +1000" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2011-01-24 09:30:41 +1100" MODIFIED_BY="Grade Profiler">ICSI compared to IVF for patients with non-male subfertility</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>ICSI compared to IVF for couples with non-male subfertility</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patients or population:</B> couples with non-male subfertility<BR/>
<B>Settings: </B>IVF clinics<BR/>
<B>Intervention:</B> ICSI<BR/>
<B>Comparison: </B>IVF</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk<SUP>1</SUP>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>IVF</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>ICSI </B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Pregnancy rate</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>OR 1.45 </B>
<BR/>(0.95 to 2.22)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>415<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Data on live birth was not available.</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>252 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>328 per 1000</B>
<BR/>(242 to 428)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Based on <LINK REF="STD-Bhattacharya-2001" TYPE="STUDY">Bhattacharya 2001</LINK>
</P>
<P>
<SUP>2</SUP>Blinding was not stated, but allocation concealment was centralised<BR/>
<SUP>3</SUP>Summary effect crosses line of no effect and appreciable benefit or harm</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-05-09 09:12:28 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2011-05-09 09:12:28 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>ICSI versus IVF</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="70" EVENTS_2="51" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-05-09 09:12:28 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.28" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="213" TOTAL_2="202" WEIGHT="0.0" Z="0.0">
<NAME>Pregnancy rate</NAME>
<GROUP_LABEL_1>IVF</GROUP_LABEL_1>
<GROUP_LABEL_2>ICSI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ICSI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours IVF</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2217827036287563" CI_START="0.9454443394432932" EFFECT_SIZE="1.4493349787467436" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="51" LOG_CI_END="0.34670158150418756" LOG_CI_START="-0.024364034015331326" LOG_EFFECT_SIZE="0.16116877374442812" MODIFIED="2011-05-02 09:27:06 +1000" MODIFIED_BY="[Empty name]" ORDER="32463" O_E="0.0" SE="0.2179657793605858" STUDY_ID="STD-Bhattacharya-2001" TOTAL_1="213" TOTAL_2="202" VAR="0.047509080972267574" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-05-02 09:21:23 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2011-05-02 09:21:23 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-05-02 09:21:23 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAARUAAAE4CAIAAAD6vvBdAAAMsklEQVR42u3dsW5kRRbG8ZZICBxM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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-05-16 22:58:57 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2011-05-16 22:58:36 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-08-19 12:48:01 +1000" MODIFIED_BY="[Empty name]">PsycINFO</TITLE>
<APPENDIX_BODY MODIFIED="2011-05-16 22:58:36 +1000" MODIFIED_BY="[Empty name]">
<P>1 Fertilization in Vitro/ or IVF.mp. (276)<BR/>2 (in vitro fertilization or in vitro fertilisation).mp. (393)<BR/>3 ICSI.mp. or Sperm Injections, Intracytoplasmic/ (34)<BR/>4 intracytoplasmic sperm$.mp. (23)<BR/>5 intra-cytoplasmic sperm$.mp. (0)<BR/>6 intra cytoplasmic sperm$.mp. (0)<BR/>7 or/3-6 (39)<BR/>8 or/1-2 (449)<BR/>9 7 and 8 (26)<BR/>10 limit 9 to yr="2009 -Current" (5)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2011-05-16 22:58:41 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-08-19 12:48:26 +1000" MODIFIED_BY="[Empty name]">CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2011-05-16 22:58:41 +1000" MODIFIED_BY="[Empty name]">
<P>1 Fertilization in Vitro/ or IVF.mp. (2027)<BR/>2 (in vitro fertilization or in vitro fertilisation).mp. (1222)<BR/>3 Zona Pellucida/ or partial zona dissection.mp. (84)<BR/>4 (partial dissecti$ adj5 zona).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (2)<BR/>5 PZD.mp. (6)<BR/>6 (subzonal adj5 insemination).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (19)<BR/>7 (subzonal adj5 micro$).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (9)<BR/>8 SUZI.mp. (13)<BR/>9 (conventional adj4 assisted reproduct$).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (2)<BR/>10 conventional technique$.mp. (268)<BR/>11 or/1-10 (2651)<BR/>12 ICSI.mp. or Sperm Injections, Intracytoplasmic/ (669)<BR/>13 intracytoplasmic sperm$.mp. (383)<BR/>14 intra-cytoplasmic sperm$.mp. (5)<BR/>15 intra cytoplasmic sperm$.mp. (5)<BR/>16 or/12-15 (760)<BR/>17 11 and 16 (462)<BR/>18 limit 17 to yr="2009 -Current" (34)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2011-05-16 22:58:49 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2010-08-19 12:49:21 +1000" MODIFIED_BY="[Empty name]">MEDLINE</TITLE>
<APPENDIX_BODY MODIFIED="2011-05-16 22:58:49 +1000" MODIFIED_BY="[Empty name]">
<P>1 Fertilization in Vitro/ or IVF.mp. (25000)<BR/>2 (in vitro fertilization or in vitro fertilisation).mp. (14024)<BR/>3 Zona Pellucida/ or partial zona dissection.mp. (2962)<BR/>4 (partial dissecti$ adj5 zona).mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier] (6)<BR/>5 PZD.mp. (61)<BR/>6 (subzonal adj5 insemination).mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier] (81)<BR/>7 (subzonal adj5 micro$).mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier] (40)<BR/>8 SUZI.mp. (102)<BR/>9 (conventional adj4 assisted reproduct$).mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier] (10)<BR/>10 conventional technique$.mp. (4128)<BR/>11 or/1-10 (33921)<BR/>12 ICSI.mp. or Sperm Injections, Intracytoplasmic/ (5196)<BR/>13 intracytoplasmic sperm$.mp. (3777)<BR/>14 intra-cytoplasmic sperm$.mp. (98)<BR/>15 intra cytoplasmic sperm$.mp. (98)<BR/>16 or/12-15 (5987)<BR/>17 randomized controlled trial.pt. (297622)<BR/>18 controlled clinical trial.pt. (82260)<BR/>19 randomized.ab. (212030)<BR/>20 placebo.tw. (128230)<BR/>21 clinical trials as topic.sh. (150436)<BR/>22 randomly.ab. (156631)<BR/>23 trial.ti. (91166)<BR/>24 (crossover or cross-over or cross over).tw. (49072)<BR/>25 or/17-24 (723650)<BR/>26 (animals not (humans and animals)).sh. (3437239)<BR/>27 25 not 26 (669628)<BR/>28 27 and 11 and 16 (444)<BR/>29 (2010$ or 2009$).ed. (1520912)<BR/>30 28 and 29 (69)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2011-05-16 22:58:57 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2010-08-19 12:49:45 +1000" MODIFIED_BY="[Empty name]">EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2011-05-16 22:58:57 +1000" MODIFIED_BY="[Empty name]">
<P>1 Fertilization in Vitro/ or IVF.mp. (32559)<BR/>2 (in vitro fertilization or in vitro fertilisation).mp. (15492)<BR/>3 Zona Pellucida/ or partial zona dissection.mp. (3893)<BR/>4 (partial dissecti$ adj5 zona).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer] (6)<BR/>5 PZD.mp. (72)<BR/>6 (subzonal adj5 insemination).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer] (100)<BR/>7 (subzonal adj5 micro$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer] (40)<BR/>8 SUZI.mp. (116)<BR/>9 (conventional adj4 assisted reproduct$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer] (13)<BR/>10 conventional technique$.mp. (4471)<BR/>11 or/1-10 (41690)<BR/>12 ICSI.mp. or Sperm Injections, Intracytoplasmic/ (8651)<BR/>13 intracytoplasmic sperm$.mp. (8441)<BR/>14 intra-cytoplasmic sperm$.mp. (146)<BR/>15 intra cytoplasmic sperm$.mp. (146)<BR/>16 or/12-15 (9037)<BR/>17 11 and 16 (5799)<BR/>18 Clinical Trial/ (787522)<BR/>19 Randomized Controlled Trial/ (266690)<BR/>20 exp randomization/ (51069)<BR/>21 Single Blind Procedure/ (12635)<BR/>22 Double Blind Procedure/ (95075)<BR/>23 Crossover Procedure/ (28246)<BR/>24 Placebo/ (162929)<BR/>25 Randomi?ed controlled trial$.tw. (53168)<BR/>26 Rct.tw. (5662)<BR/>27 random allocation.tw. (963)<BR/>28 randomly allocated.tw. (13911)<BR/>29 allocated randomly.tw. (1628)<BR/>30 (allocated adj2 random).tw. (671)<BR/>31 Single blind$.tw. (9957)<BR/>32 Double blind$.tw. (109055)<BR/>33 ((treble or triple) adj blind$).tw. (208)<BR/>34 placebo$.tw. (145524)<BR/>35 prospective study/ (151181)<BR/>36 or/18-35 (1060029)<BR/>37 case study/ (9832)<BR/>38 case report.tw. (189529)<BR/>39 abstract report/ or letter/ (748392)<BR/>40 or/37-39 (944266)<BR/>41 36 not 40 (1028765)<BR/>42 (2009$ or 2010$).em. (1641637)<BR/>43 17 and 41 and 42 (214)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>